The Evolving Business Case for HER3 Inhibitors
The HER3 inhibitors Market is rapidly emerging as one of oncology's most watched therapeutic areas, powered by fresh insights into cancer resistance mechanisms, sharper diagnostic tools, and innovative drug development approaches.


